Policy

Taking an evidence-led and harm reduction-focused
approach to drug policy reform

Policy Publications

Reports written by our Policy Team, detailing their analyses and recommendations for drug policy.

Preventing and reducing the harms related to the non-medical use of benzodiazepines by UK young people

Coming 2025.

TBC 2025

Unpublished

---

Policy Team

Monica Richards

Head of Policy

Zahraa Mushtaq

Policy Development Officer

Matt Jefford

Policy Development Officer

Oliver Lomond

Policy Development Officer

Fintan Holland

Policy Development Officer

Lizzie Roberts

Policy Development Officer

Joe Sharp

Policy Development Officer

Joshua O'Hanlon

Policy Development Officer

Sarena Zalita

Policy Development Officer

Fiona Murray

Policy Communications Officer

Bethan Mapes

Policy Communications Officer

Savvina Antoniadou

Policy Communications Officer

Saira Chowdhry

Policy Communications Officer

Laura Feather

Policy Communications Officer

Holly Woodward

Policy Impact Officer

Sasha Howells

Policy Impact Officer

Mila Paisley

Policy Impact Officer

Neha Modha

Policy Impact Officer

Anshuman Das

Policy Impact Officer

Our work

• Writing a policy brief advocating for drug policy based on evidence that benefits young people’s health and wellbeing, with a particular focus on non-medical benzo use.
• Fostering professional relationships with MPs and drug policy reform groups across the political spectrum, in support of evidence-based drug policy.
• Working with the Research team to communicate their findings in an accessible, appropriate way for policymakers, and the Media team to amplify our team’s output.

Co-Project Lead and Co-Head of Policy, Monica Richards, speaking with Mr Mark Colhoun (Secretary, International Narcotics Control Board) at the UN Commission on Narcotic Drugs in Vienna – 5 December 2023.

Do you have a question? Do you want to collaborate? Contact us